A 2021 analysis published in Cardiovascular Diabetology found that semaglutide produced significant reductions in triglycerides and total cholesterol alongside its weight loss effects, with improvements correlating strongly with the degree of weight lost (Husain et al., Cardiovascular Diabetology, 2021, Tirzepatide and Cholesterol: Does the Dual Mechanism Help More For patients with significant lipid abnormalities, tirzepatide may offer an advantage over semaglutide
When reimbursement expands, as in the earlier example of the NHS agreement for Mounjaro, an even wider group of doctors, in particular general practitioners (GPs), will be exposed to AOMs as prescribers
These are temporary and signs that a persons toxic load is high
HS is increasingly recognized as a disease driven by systemic inflammation and metabolic dysfunction, with evidence supporting the use of treatments that address both pathways
Abdomen (Stomach) This is one of the most common and convenient areas